Evidence map›Paper›PMID 30507913›Full record

ArticleJournal of visualized experiments : JoVE2018

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles.

John W Hickey, Jonathan P Schneck

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

John W HickeyDepartment of Biomedical Engineering, School of Medicine, Johns Hopkins University; Institute for Cell Engineering, School of Medicine, Johns Hopkins University; Institute for Nanobiotechnology, Johns Hopkins University; Department of Pathology, School of Medicine, Johns Hopkins University.
Jonathan P SchneckInstitute for Cell Engineering, School of Medicine, Johns Hopkins University; Department of Pathology, School of Medicine, Johns Hopkins University; jschnec1@jhmi.edu.

Funding

The influence of TCR spatial organization on the T cell responsesP01AI072677 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SCHNECK, JONATHAN P · 2008 to 2012
$10.3M
Use of aAPC for Melanoma Adoptive ImmunotherapyR01CA108835 · NCI · JOHNS HOPKINS UNIVERSITY · PI SCHNECK, JONATHAN P · 2004 to 2015
$3.3M
Antigen-specific T cell Redirectors, ATR, for immunotherapyR21CA185819 · NCI · JOHNS HOPKINS UNIVERSITY · PI SCHNECK, JONATHAN P · 2015 to 2016
$388k
NCI NIH HHS R01 CA108835NCI NIH HHS R21 CA185819NIAID NIH HHS P01 AI072677
6 · The paper itself

Abstract

We have developed a tool to both enrich and expand antigen-specific T cells. This can be helpful in cases such as to A) detect the existence of antigen-specific T cells, B) probe the dynamics of antigen-specific responses, C) understand how antigen-specific responses affect disease state such as autoimmunity, D) demystify heterogeneous responses for antigen-specific T cells, or E) utilize antigen-specific cells for therapy. The tool is based on a magnetic particle that we conjugate antigen-specific and T cell co-stimulatory signals, and that we term as artificial antigen presenting cells (aAPCs). Consequently, since the technology is simple to produce, it can easily be adopted by other laboratories; thus, our purpose here is to describe in detail the fabrication and subsequent use of the aAPCs. We explain how to attach antigen-specific and co-stimulatory signals to the aAPCs, how to utilize them to enrich for antigen-specific T cells, and how to expand antigen-specific T cells. Furthermore, we will highlight engineering design considerations based on experimental and biological information of our experience with characterizing antigen-specific T cells.

Indexed as

Magnetite NanoparticlesAntigen-Presenting CellsBioengineeringHumansT-LymphocytesMagnetite Nanoparticles

Identifiers

PMID30507913
PMCPMC6724533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.